Randomized, Double-Blind, Placebo-Controlled Trial of Oral Sirolimus for Restenosis Prevention in Patients With In-Stent Restenosis: The Oral Sirolimus to Inhibit Recurrent In-stent Stenosis (OSIRIS) Trial
暂无分享,去创建一个
A. Kastrati | J. Mehilli | J. Dirschinger | F. Dotzer | J. Pache | H. Schühlen | J. Hausleiter | A. Schömig | U. Heemann | M. Vogeser | G. Pogatsa-Murray | D. Zohlnhöfer | Christoph Goos | G. Pogátsa-Murray
[1] K. Kent,et al. Five-Year Follow-Up After Intracoronary Gamma Radiation Therapy for In-Stent Restenosis , 2004, Circulation.
[2] William Wijns,et al. Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS) , 2003, The Lancet.
[3] Jeffrey W Moses,et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. , 2003, The New England journal of medicine.
[4] R. Virmani,et al. Pilot study of oral rapamycin to prevent restenosis in patients undergoing coronary stent therapy: Argentina Single-Center Study (ORAR Trial). , 2003, The Journal of invasive cardiology.
[5] C. Macaya,et al. A randomized comparison of repeat stenting with balloon angioplasty in patients with in-stent restenosis. , 2003, Journal of the American College of Cardiology.
[6] D. Burkhoff,et al. Use of Rapamycin Slows Progression of Cardiac Transplantation Vasculopathy , 2003, Circulation.
[7] P. Teirstein,et al. Pilot Trial of Oral Rapamycin for Recalcitrant Restenosis , 2003, Circulation.
[8] Muzaffer Degertekin,et al. TAXUS III Trial: In-Stent Restenosis Treated With Stent-Based Delivery of Paclitaxel Incorporated in a Slow-Release Polymer Formulation , 2003, Circulation.
[9] P. Serruys,et al. Two-Year Angiographic and Intravascular Ultrasound Follow-Up After Implantation of Sirolimus-Eluting Stents in Human Coronary Arteries , 2003, Circulation.
[10] P. Serruys,et al. Sirolimus-Eluting Stent for the Treatment of In-Stent Restenosis: A Quantitative Coronary Angiography and Three-Dimensional Intravascular Ultrasound Study , 2003, Circulation.
[11] B. Meiser,et al. Quantification of Sirolimus by Liquid Chromatography-Tandem Mass Spectrometry Using On-Line Solid-Phase Extraction , 2002, Clinical chemistry and laboratory medicine.
[12] G. Stone,et al. Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome. , 1999, Circulation.
[13] M. Hadamitzky,et al. Clinical and angiographic follow‐up after balloon angioplasty with provisional stenting for coronary in‐stent restenosis , 1999, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[14] C. Wegner,et al. Neointimal formation after balloon-induced vascular injury in Yucatan minipigs is reduced by oral rapamycin. , 1999, Journal of cardiovascular pharmacology.
[15] S Marx,et al. Inhibition of intimal thickening after balloon angioplasty in porcine coronary arteries by targeting regulators of the cell cycle. , 1999, Circulation.
[16] S. Sehgal,et al. Rapamycin (AY-22,989), a new antifungal antibiotic. II. Fermentation, isolation and characterization. , 1975, The Journal of antibiotics.
[17] S. Sehgal,et al. Rapamycin (AY-22,989), a new antifungal antibiotic. I. Taxonomy of the producing streptomycete and isolation of the active principle. , 1975, The Journal of antibiotics.